Progressionshemmung bei Lebererkrankungen

Literatur

• 1 Beuers U, Wiedmann K H, Kleber G, Fleig W E. Therapie der autoimmunen Hepatitis, primär biliären Zirrhose und primär sklerosierenden Cholangitis. Konsensus der DGVS.  Z Gastroenterol. 1997;  35 1041-1049
• 2 Bomford A, Williams R. Long term results of venosection therapy in idiopathic haemochromatosis.  Quart J Med. 1976;  45 611-623
• 3 Corpechot C, Carrat F, BonnandA-M, Poupon R E, Poupon R. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis.  Hepatology. 2000;  32 1196-1199
• 4 Dienstag J L, Goldin R D, Heathcote E J, Hann H W L, Woessner M, Stephenson S L, Gardner S, Gray D F, Schiff E R. Histological outcome during long-term lamivudine therapy.  Gastroenterology. 2003;  124 105-117
• 5 Hadziyannis S J, Tassopoulos N C, Heathcote E J, Chang T -T, Kitis G, Rizzetto M, Marcellin P, Lim S G, Goodman Z, Wulfsohn S, Xiong S, Fry J, Brosgart C L. for the Adefovir Dipivoxil 438 Study group . Adefovir dipivoxil for the treatment of hepatitis Be antigen-negative chronic hepatitis B.  N Engl J Med. 2003;  348 800-807
• 6 Nishiguchi S, Shiom S, Nakatani S, Takeda T, Fukuda K, Tamori A, Habu D, Tanaka T. Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis.  Lancet. 2001;  357 196-197
• 7 Plauth M, Ferenci P, Holm E, vom Dahl S, Kondrup J, Müller M J, Nolte W. DGEM-Leitlinie Enterale Ernährung: Hepatologie.  Akt Ernähr Med. 2003;  28 (Suppl 1) S87-S92
• 8 Poupon R E, Lindor K D, Cauch-Dudeck K, Dickson E R, Poupon R, Heathcote E J. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.  Gastroenteroogy. 1997;  113 884-890
• 9 Poynard T, McHutchinson J, Manns M, Trepo C, Lindsay K, Goodman Z, Ling M -H, Albrecht J. for the PEG-fibrosis project group . Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.  Gastroenterology. 2002;  122 1303-1313
• 10 Schenker S. Alcoholic liver disease: evaluation of natural historyand prognostic factors.  Hepatology. 1984;  4 36S-43S
• 11 Stickel F, Seitz H K, Hahn E G, Schuppan D. Alkoholische Lebererkrankung- etablierte und experimentelle Therapieansätze.  Z Gastroenterol. 2003;  41 333-342
• 12 Stiehl A, Rudolph G, Klöters-Plachky P. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment.  Hepatology. 2002;  36 151-156